Carrier containing immunoglobulinlg gene, construction method and uses thereof
A technology of immunoglobulin and its construction method, which is applied in the field of vectors containing immunoglobulin genes and their construction, and can solve problems such as the construction of fusion expression vectors for human IgG1 Fc segments that have not been seen yet
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Implementation 1 Construction of recombinant vector pBV220 / Fc
[0044] 1. Capture the gene encoding the Fc fragment of the heavy chain constant region of human immunoglobulin IgG1 (Human lmmunoglobulin gamma-1)
[0045] The specific method is as follows:
[0046] According to the reported human IgG1 gene sequence (Genbank accession number is BC006402), design and synthesize specific primers. The Fc fragment caught is located at the 816-1523bp position of the above known sequence. The primers are as follows:
[0047] Upstream primers: ATGGAGCCCAAATCTTGTGACAAAACTC-3'(S EQID No.2)
[0048] EcoR I
[0049] Downstream primers: G CGATCCGCCACCGCC CCGTCGCACTCATTTACCC
[0050] BamH I Xhol I linker (linker)
[0051] G-3' (SEQ ID No.3)
[0052]The upstream primer contains an EcoR I restriction site, and the downstream primer has a gene encoding a 5-peptide Gly-Gly-Gly-Gly-Ser flexible linker (linker). The 5 amino acids encoded by this gene ha...
Embodiment 2
[0070] Example 2 Take the fusion expression of staphylokinase (SA K) as an example to illustrate the application of this vector in prolonging the half-life of recombinant protein drugs in vivo
[0071] Natural staphylokinase (staphylokinase, Sak) is a single-chain protein synthesized by lysogenic phage of Staphylococcus aureus, consisting of 136 amino acids. Staphylokinase itself has no enzymatic activity, it can combine with plasminogen on the surface of thrombus 1:1 to form a complex, and further activate the fibrinolytic system. Because Sak activates plasmin with fibrin specificity and low bleeding tendency, the thrombolytic effect of Sak does not affect the levels of fibrinogen, plasminogen and α2-antiplasmin in plasma, and it is effective for old thrombus And platelet-rich thrombus has a stronger lytic effect than traditional thrombolytic drugs, so Sak is a promising thrombolytic agent.
[0072] 1. The method of cloning SAK into the recombinant expression vector pBV220 / F...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com